BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 81218)

  • 1. Correlation of computed tomography and serum tumor markers in metastatic retroperitoneal testicular tumor.
    Javadpour N; Doppman JL; Bergman SM; Anderson T
    J Comput Assist Tomogr; 1978 Apr; 2(2):176-80. PubMed ID: 81218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum markers in testicular tumors.
    Narayana AS; Loening S; Weimar G; Culp DA
    J Urol; 1979 Jan; 121(1):51-3. PubMed ID: 83396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
    Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
    Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
    Javadpour N; McIntire KR; Waldmann TA; Scardino PT; Bergman S; Anderson T
    J Urol; 1978 Jun; 119(6):759-62. PubMed ID: 77918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for stage I nonseminoma.
    Feldman DR
    J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
    [No Abstract]   [Full Text] [Related]  

  • 14. Epididymal melanotic neuroectodermal tumor of infancy.
    Ricketts RR; Majmudarr B
    Hum Pathol; 1985 Apr; 16(4):416-20. PubMed ID: 2579889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of endodermal sinus tumour, testicular teratoma and alpha1-fetoprotein.
    Gariépy G; Lafortune M; Poisson R
    Can Med Assoc J; 1976 Aug; 115(3):223-6. PubMed ID: 60168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
    Otto T; Virchow S; Fuhrmann C; Steinberg F; Streffer C; Goepel M; Rübben H
    Urol Res; 1997; 25(2):121-4. PubMed ID: 9144879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratubular trophoblasts in the contralateral testis caused elevation of serum human chorionic gonadotropin following complete remission of stage II testicular tumor: a case report.
    Nitta S; Kawai K; Onozawa M; Ando S; Miyazaki J; Nagata C; Noguchi M; Yamasaki K; Uchida K; Iwamoto T; Nishiyama H
    Jpn J Clin Oncol; 2013 Jan; 43(1):83-6. PubMed ID: 23136239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.